Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Chemoradiation Followed by Paclitaxel for Poor-Risk Stage III NSCLC
NCT00003158Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Feb 1998
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in non-small cell lung cancer (NSCLC), sponsored by SWOG Cancer Research Network. Started Feb 1998; status: completed.
02
Drugs
paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003158.